Company news
Innoveren Scientific Inc. news in 2019
Innoveren Scientific Inc.'s news releases, calls and decks from 2019, newest first.
H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD
November 18, 2019
H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors
July 30, 2019
H-CYTE Bolsters Board of Directors With Appointment of Dr. Andre Terzic to Board of Directors
July 29, 2019
H-CTYE Comments on Recent Promotional Activity
July 16, 2019
Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol
July 12, 2019
Medovex Corporation Updates Name Change and Full Rebranding to H-CYTE
July 1, 2019
Medovex’s Transition to H-CYTE Underscores Biotechnology Focus
June 24, 2019
Medovex Corporation Announces Recent Management Appointments
April 29, 2019
Medovex Corporation Closes Financing for a Total $7.2M Under Existing Securities Purchase Agreement
April 8, 2019
Medovex Corporation Receives an Additional $1.25 Million Under Existing Securities Purchase Agreement
March 18, 2019
Medovex Corporation Announces Name Change and Full Rebranding to Blue Zone Health
February 4, 2019
Medovex Corporation Receives an Additional $2.9 Million Under Existing Securities Purchase Agreement
January 28, 2019
Medovex Corporation Enters into Securities Purchase Agreement
January 16, 2019
Medovex Corporation Announces New Board Appointments
January 15, 2019
Medovex Corporation Closes Acquisition of Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
January 14, 2019